A Correlative Study of Biomarkers of Resistance in Patients With Castrate Resistant Prostate Cancer Treated With Abiraterone
Phase of Trial: Phase IV
Latest Information Update: 24 Jun 2015
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Prostate cancer
- Focus Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 19 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.